NEXT GENERATION OF IMMUNO-ONCOLOGY
Immunotherapystarts before the checkpoint.
Aveta applies principles of evolutionary biology to develop oral therapies that reprogram the tumor–immune ecosystem upstream of checkpoints and thus changing the conditions that allow cancer to suppress immunity, adapt and persist.
Cold or hot, tumors can still evade immunity.
Aveta Biomics drugs are designed for both.
Aveta’s therapies are designed to activate immune-cold tumors and restore productive immunity in tumors that are already inflamed but functionally suppressed.
Reprogram the tumor. Transform the outcome.
01
Designed to Prevent Drug Resistance
Acts across multiple immune pathways, making cancer escape through any single route more difficult.
02
The body’s own immune logic
Designed around functions of endogenous metabolites that regulate human immune activity.